These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11230883)

  • 1. Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders.
    Weinmann M; Becker G; Einsele H; Bamberg M
    Radiother Oncol; 2001 Mar; 58(3):235-46. PubMed ID: 11230883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders.
    Paulino AC; Reddy SP
    Am J Hosp Palliat Care; 1996; 13(6):32-5. PubMed ID: 8945101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study of low-dose splenic irradiation for the treatment of chronic lymphocytic and prolymphocytic leukaemias.
    Singh AK; Bates T; Wetherley-Mein G
    Scand J Haematol; 1986 Jul; 37(1):50-8. PubMed ID: 3489979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic irradiation in chronic lymphocytic leukemia.
    Chisesi T; Capnist G; Dal Fior S
    Eur J Haematol; 1991 Apr; 46(4):202-4. PubMed ID: 2015875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Splenic irradiation: apropos of 8 cases. Clinical indications and literature review].
    Ibáñez Villoslada C; González San Segundo C; de Torres Olombrada MV; García García R; Santos Miranda JA
    An Med Interna; 2007 May; 24(5):231-4. PubMed ID: 17907888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic irradiation for prolymphocytic leukemia: is it preferable as an initial treatment or not?
    Yamamoto K; Hamaguchi H; Nagata K; Shibuya H; Takeuchi H
    Jpn J Clin Oncol; 1998 Apr; 28(4):267-9. PubMed ID: 9657013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
    Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
    J Clin Pathol; 1989 Jun; 42(6):567-84. PubMed ID: 2738163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic irradiation as primary therapy for prolymphocytic leukemia.
    Kiss A; Haubenstock A; Bognar H; Scheiderbauer R; al-Mobarak M; Base W
    Am J Hematol; 1989 Mar; 30(3):188-9. PubMed ID: 2916562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of chronic haematological malignancies.
    Ho AD
    Baillieres Clin Haematol; 1991 Jan; 4(1):197-221. PubMed ID: 2039859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic irradiation for splenomegaly: A systematic review.
    Zaorsky NG; Williams GR; Barta SK; Esnaola NF; Kropf PL; Hayes SB; Meyer JE
    Cancer Treat Rev; 2017 Feb; 53():47-52. PubMed ID: 28063304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose palliative radiotherapy for splenomegaly in hematologic disorders.
    Lavrenkov K; Krepel-Volsky S; Levi I; Ariad S
    Leuk Lymphoma; 2012 Mar; 53(3):430-4. PubMed ID: 21848363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
    Moccia F; Casti P; Morra L
    Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic irradiation for hairy cell leukaemia.
    al-Moundhri M; Graham PH
    Australas Radiol; 1997 Nov; 41(4):361-2. PubMed ID: 9409029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity.
    Zhang B; Lewis SM
    Eur J Haematol; 1989 Jul; 43(1):63-6. PubMed ID: 2767243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
    Ginaldi L; De Martinis M; Matutes E; Farahat N; Morilla R; Catovsky D
    J Clin Pathol; 1998 May; 51(5):364-9. PubMed ID: 9708202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of splenic irradiation in chronic lymphocytic leukemia.
    Guiney MJ; Liew KH; Quong GG; Cooper IA
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):225-9. PubMed ID: 2912945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders.
    Sager O; Beyzadeoglu M; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Akin M; Gundem E; Dirican B
    Tumori; 2015; 101(1):84-90. PubMed ID: 25702680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
    Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
    Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of low-malignancy lymphomas by spleen irradiation].
    Słomkowski M; Jeleniewska A; Apel D; Sablińska K; Maj S
    Acta Haematol Pol; 1990; 21(1):85-91. PubMed ID: 2260412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment.
    Troussard X; Maitre E
    J Cell Mol Med; 2024 Feb; 28(3):e18060. PubMed ID: 38095234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.